greeksoup/ stock research
Stock research / United States / NTLA / Planned sales

Intellia Therapeutics, Inc. planned insider sales

In the last twelve months insiders at Intellia Therapeutics, Inc. filed 4 Form 144 notices of planned sales, 173,248 shares worth $1.9 million at the time of filing, from 3 sellers. The latest, filed 5 October 2026: Eliana Clark (officer), 57,750 shares worth $736,312, planned for around 5 October 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
5 October 2026Eliana ClarkOfficer57,750$736,3125 October 2026None on Form 4 yetMorgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
20 August 2026Leonard John MOfficer, Director22,675$293,64120 August 202622,675 shares from 20 August 2026UBS Financial Services, Inc.Stock Option ExerciseForm 144
2 July 2026Edward DulacOfficer4,677$80,6312 July 202612,788 shares from 2 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
11 December 2025Leonard John MOfficer, Director88,146$822,40211 December 2025122,292 shares from 11 December 2025UBS Financial Services, Inc.Restricted Vesting; Stock Option ExerciseForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?